EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Clonal hematopoiesis and thromboembolic diseases: a review

Jee Hyuk Byun, Jaekeun Jung, Janghee Woo

Journal of Thrombosis and Haemostasis · 2025-09 · 23 (9) · 2697-2709

DOI: 10.1016/j.jtha.2025.05.035 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-09. Verfasst von Jee Hyuk Byun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA; Winship Cancer Institute of Emory Universi…. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Thromboembolism. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Emory University, Emory University Winship Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal hematopoiesis of indeterminate potential (CHIP) has been identified as a novel risk factor for cardiovascular diseases, primarily mediated by CHIP-induced systemic inflammation. Emerging evidence suggests that CHIP may also contribute to the risk of thromboembolic diseases. This review highlights recent findings on the impact of CHIP on various thromboembolic conditions, such as deep vein thrombosis, pulmonary embolism, chronic thromboembolic pulmonary hypertension, and ischemic stroke. Studies have demonstrated an association between CHIP and an increased risk of deep vein thrombosis, pulmonary embolism, chronic thromboembolic pulmonary hypertension and ischemic stroke. CHIP-induced systemic inflammation may amplify vascular endothelial damage and complement cascade activation, which in turn promote platelet activation, fibrin deposition, and the release of neutrophil extracellular traps. These processes collectively may drive thromboembolic events. Further mechanistic studies are warranted to elucidate the biological pathways through which CHIP influences the risk of thromboembolic diseases and to identify potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisThromboembolismHumansPlatelet ActivationAnimalsRisk FactorsPulmonary EmbolismVenous ThrombosisComplement ActivationInflammationExtracellular TrapsIschemic StrokeBlood Coagulation

Stichwörter der Autor:innen

chronic thromboembolic pulmonary hypertensionclonal hematopoiesis of indeterminate potentialdeep vein thrombosisischemic strokepulmonary embolism

Autor:innen und Institutionen

  • Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.
  • Eastern Virginia Medical School, Norfolk, Virginia, USA.
  • Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA. Electronic address: janghee.woo@emory.edu.

Förderung

  • Emory University
  • Emory University Winship Cancer Institute

Zitieren

APA

Byun, J. H., Jung, J., & Woo, J. (2025). Clonal hematopoiesis and thromboembolic diseases: a review. Journal of Thrombosis and Haemostasis, 23(9), 2697-2709. https://doi.org/10.1016/j.jtha.2025.05.035

Vancouver

Byun JH, Jung J, Woo J. Clonal hematopoiesis and thromboembolic diseases: a review. Journal of Thrombosis and Haemostasis. 2025;23(9):2697-2709. doi:10.1016/j.jtha.2025.05.035

BibTeX
@article{Byun2025,
  author = {Byun, Jee Hyuk and Jung, Jaekeun and Woo, Janghee},
  title = {Clonal hematopoiesis and thromboembolic diseases: a review},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  volume = {23},
  number = {9},
  pages = {2697--2709},
  doi = {10.1016/j.jtha.2025.05.035}
}
Kostenlos starten →